Huntington National Bank’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4339 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4339 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4309 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4288 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4214 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4094 |
|
|
2023
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4044 |
|
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3951 |
|
|
2023
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3892 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3695 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3646 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2674 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2665 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2589 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2498 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2241 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2136 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2040 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2012 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1962 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1980 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2057 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2060 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1984 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2018 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1988 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2040 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2028 |
|